Maternal autoimmune bullous disease (MABD) is a rare but serious condition that can occur during pregnancy, typically in the second or third trimester. It is an autoimmune disorder that affects the skin and mucous membranes, causing blisters and erosions. The condition can be life-threatening for both the mother and the fetus if left untreated. In this article, we will explore the different types of MABD and their defining features, as well as the symptoms, diagnosis, and treatment options.
Autoimmune bullous diseases are a group of rare skin disorders that occur when the immune system attacks the skin and mucous membranes, resulting in blister formation. Maternal autoimmune bullous diseases can complicate pregnancy and can be a significant risk factor for the mother and the developing fetus. Early diagnosis and appropriate management of maternal autoimmune bullous diseases are essential to ensure a successful pregnancy outcome.
Autoimmune bullous diseases are a group of disorders characterized by the presence of antibodies that target specific proteins within the skin or mucous membranes. These antibodies cause inflammation and blistering, which can be localized or widespread. In MABD, the mother’s immune system mistakenly targets these proteins, leading to the development of blisters and erosions.
There are several types of MABD, each with its own distinct set of symptoms and associated complications. The most common types of MABD are pemphigoid gestationis, linear IgA bullous dermatosis of pregnancy, and bullous pemphigoid.
- Pemphigoid Gestationis: Pemphigoid gestationis (PG) is the most common type of MABD, accounting for approximately 70% of cases. It typically presents during the second or third trimester, but can also occur during the postpartum period. The hallmark symptom of PG is the presence of pruritic (itchy) urticarial papules and plaques (PUPP) that progress to tense blisters and erosions. These lesions usually start on the abdomen and can spread to other areas of the body, including the limbs and face. PG is caused by the production of autoantibodies against the protein BP180, which is located in the basement membrane of the skin. In addition to skin symptoms, PG can also cause liver damage, preterm labor, and fetal distress.
- Linear IgA Bullous Dermatosis of Pregnancy: Linear IgA bullous dermatosis of pregnancy (LABD) is a rare type of MABD, accounting for less than 10% of cases. It is characterized by the presence of tense blisters and erosions on the skin and mucous membranes, as well as a linear pattern of immunoglobulin A (IgA) deposition in the basement membrane zone. LABD typically presents in the second or third trimester, but can also occur during the postpartum period. The condition is caused by the production of autoantibodies against the protein BP180, as well as other proteins such as laminin-332 and type VII collagen. LABD can cause significant morbidity in both the mother and fetus, including prematurity, fetal distress, and neonatal pemphigoid.
- Bullous Pemphigoid: Bullous pemphigoid (BP) is a rare autoimmune disease that can occur in both men and women of any age. However, in pregnant women, it is classified as a type of MABD. BP is characterized by the presence of large, tense blisters and erosions on the skin and mucous membranes. The condition is caused by the production of autoantibodies against the protein BP180 and BP230, both of which are located in the basement membrane zone. BP typically presents in the third trimester, but can also occur in the postpartum period. In addition to skin symptoms, BP can cause eye complications, such as conjunctivitis and scarring, as well as neurological symptoms, such as seizures and encephalopathy.
Causes
The exact causes of MABD are not fully understood, but research has identified several potential factors that may contribute to its development. In this article, we will discuss the top 20 causes of MABD and their implications.
- Genetic predisposition: Some studies suggest that certain genetic factors may make individuals more susceptible to developing MABD. However, the exact genes involved in this condition are not yet fully understood.
- Hormonal changes: Pregnancy is associated with significant hormonal changes, which can affect the immune system and lead to the development of MABD.
- Immunologic dysregulation: MABD is caused by the production of autoantibodies that attack the body’s own tissues. This may be due to a dysregulation of the immune system, which results in the loss of self-tolerance.
- Environmental factors: Exposure to certain environmental triggers, such as drugs or infections, may contribute to the development of MABD. For example, some cases of MABD have been linked to herpes simplex virus (HSV) infection.
- Age: MABD is more common in older women, which may be related to changes in immune function that occur with age.
- History of autoimmune disease: Women with a history of autoimmune disease may be at increased risk for developing MABD during pregnancy.
- Prior pregnancies: Women who have previously had MABD during pregnancy are at increased risk for developing the condition again in subsequent pregnancies.
- HLA genotype: The HLA system is a group of genes that help regulate the immune system. Certain HLA genotypes have been associated with an increased risk of MABD.
- Gestational age: MABD is more common in the later stages of pregnancy, particularly in the third trimester.
- Type of delivery: Women who deliver by caesarean section may be at increased risk for developing MABD, although the reasons for this are not fully understood.
- In vitro fertilization: Some studies suggest that women who conceive through in vitro fertilization (IVF) may be at increased risk for developing MABD.
- Multiparity: Women who have had multiple pregnancies are at increased risk for developing MABD.
- Use of certain medications: Certain medications, such as antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs), have been linked to the development of MABD.
- Autoantibody profile: The type and level of autoantibodies present in a woman’s blood can help predict her risk of developing MABD.
- Fetal sex: Some studies suggest that women carrying male fetuses may be at increased risk for developing MABD.
- Maternal stress: High levels of stress during pregnancy may be associated with an increased risk of MABD.
- Maternal nutrition: Poor maternal nutrition may contribute to the development of MABD.
- Smoking: Smoking during pregnancy may increase the risk of developing MABD.
- Obesity: Women who are obese before or during pregnancy may be at increased risk for developing MABD.
- Ethnicity: MABD is more common in certain ethnic groups, such as those of Ashkenazi Jewish descent.
- Pemphigus vulgaris: This is a rare autoimmune disorder that affects the skin and mucous membranes. It is characterized by the formation of large blisters on the skin and oral mucosa.
- Pemphigus foliaceus: This is another rare autoimmune disorder that affects the skin. It is characterized by the formation of small blisters that can easily rupture.
- Bullous pemphigoid: This is a more common autoimmune disorder that affects the elderly. It is characterized by the formation of large, tense blisters on the skin.
- Gestational pemphigoid: This is a type of bullous pemphigoid that occurs during pregnancy. It is characterized by the formation of blisters on the abdomen and thighs.
- Linear IgA bullous dermatosis: This is a rare autoimmune disorder that affects the skin. It is characterized by the formation of blisters on the skin, particularly on the trunk and extremities.
- Erythema multiforme: This is a skin condition that is characterized by the formation of target-like lesions on the skin. It can be triggered by infections, drugs, or other factors.
- Stevens-Johnson syndrome: This is a rare and severe form of erythema multiforme. It is characterized by the formation of blisters and erosions on the skin and mucous membranes.
- Toxic epidermal necrolysis: This is a rare and life-threatening form of erythema multiforme. It is characterized by widespread skin necrosis and can be triggered by drugs.
- Dermatitis herpetiformis: This is a chronic autoimmune disorder that is characterized by the formation of small blisters on the skin, particularly on the elbows, knees, and buttocks.
- Scleroderma: This is a rare autoimmune disorder that affects the skin and internal organs. It is characterized by the hardening and thickening of the skin and can cause internal organ damage.
- Systemic lupus erythematosus: This is a chronic autoimmune disorder that can affect many organs, including the skin, joints, kidneys, and heart. It is characterized by the formation of autoantibodies that attack healthy tissues.
- Rheumatoid arthritis: This is a chronic autoimmune disorder that primarily affects the joints. It is characterized by the formation of autoantibodies that attack the synovial lining of the joints.
- Psoriasis: This is a chronic autoimmune disorder that affects the skin. It is characterized by the formation of thick, scaly plaques on the skin.
- Behçet’s disease: This is a rare autoimmune disorder that can affect many organs, including the skin, eyes, and mucous membranes. It is characterized by the formation of ulcers on the skin and mucous membranes.
- Sjögren’s syndrome: This is a chronic autoimmune disorder that primarily affects the salivary and lacrimal glands. It is characterized by the formation of autoantibodies that attack these glands, leading to dryness of the mouth and eyes.
Symptoms
Symptoms of MABD in detail.
- Bullous lesions: Bullous lesions are the hallmark of autoimmune bullous diseases, and their presence is the most common symptom of MABD. These lesions are fluid-filled blisters that can appear anywhere on the skin or mucous membranes, and they can be painful, itchy, or both.
- Painful or itchy skin: The presence of bullous lesions on the skin can cause pain and/or itching, which can be severe in some cases.
- Rash: A rash may appear on the skin in addition to bullous lesions, which can further contribute to discomfort and itching.
- Fever: Fever can be a symptom of MABD and may indicate a more serious form of the disease.
- Fatigue: Fatigue is a common symptom of autoimmune disorders, and MABD is no exception. The severity of fatigue can vary from person to person.
- Joint pain: Joint pain and stiffness can be a symptom of MABD, especially in those with a form of the disease that affects the joints.
- Oral lesions: Autoimmune bullous diseases can also affect the mucous membranes of the mouth and throat, leading to painful and/or itchy lesions.
- Eye involvement: In some cases, MABD can affect the eyes, causing inflammation and redness.
- Difficulty breathing: In rare cases, MABD can affect the lungs, leading to shortness of breath or difficulty breathing.
- Swollen lymph nodes: Swollen lymph nodes can be a symptom of MABD, indicating an inflammatory response in the body.
- Nausea and vomiting: Nausea and vomiting can occur in some people with MABD, especially in those with more severe forms of the disease.
- Headaches: Headaches can be a symptom of MABD, especially in those with a form of the disease that affects the brain and nervous system.
- Muscle weakness: Muscle weakness can be a symptom of MABD, especially in those with a form of the disease that affects the muscles.
- Weight loss: Unexplained weight loss can occur in some people with MABD, especially in those with more severe forms of the disease.
- Abdominal pain: Abdominal pain can occur in some people with MABD, especially in those with a form of the disease that affects the gastrointestinal tract.
- Irregular menstruation: Irregular menstruation can be a symptom of MABD, as the disease can affect the hormonal balance in the body.
- Preterm labor: In some cases, MABD can lead to preterm labor, which can have serious implications for the health of the baby.
- Fetal growth restriction: MABD can also affect the growth and development of the fetus, leading to fetal growth restriction and other complications.
- Stillbirth: In rare cases, MABD can lead to stillbirth, highlighting the importance of early detection and prompt treatment.
- Neonatal pemphigus: Neonatal pemphigus is a rare but serious complication of MABD, where the baby develops bullous lesions shortly after birth due to the transfer
Diagnosis
Diagnosis and tests for maternal autoimmune bullous diseases.
- Clinical examination: The first step in the diagnosis of maternal autoimmune bullous disease is a thorough clinical examination. The physician will examine the skin and mucous membranes to look for the presence of blisters, erosions, and crusting.
- Skin biopsy: A skin biopsy is a procedure in which a small piece of skin is removed and examined under a microscope. This test is done to confirm the diagnosis of autoimmune bullous disease and to determine the type of disease.
- Direct immunofluorescence (DIF): Direct immunofluorescence is a laboratory test in which a sample of skin is examined under a microscope with a fluorescent antibody. This test helps to confirm the diagnosis of autoimmune bullous disease.
- Indirect immunofluorescence (IIF): Indirect immunofluorescence is a blood test that detects antibodies in the blood that may be associated with autoimmune bullous diseases.
- Enzyme-linked immunosorbent assay (ELISA): ELISA is a blood test that detects specific antibodies associated with autoimmune bullous diseases.
- Immunoblotting: Immunoblotting is a laboratory technique that is used to detect specific antibodies associated with autoimmune bullous diseases.
- Complement levels: Complement levels are blood tests that measure the levels of complement proteins in the blood. Low complement levels may be associated with autoimmune bullous diseases.
- Complete blood count (CBC): A complete blood count is a blood test that measures the number and types of blood cells. This test is done to look for anemia, which is a common complication of autoimmune bullous disease.
- Liver function tests: Liver function tests are blood tests that measure the levels of various enzymes and proteins in the blood that are produced by the liver. These tests are done to look for liver damage, which can occur in autoimmune bullous disease.
- Renal function tests: Renal function tests are blood tests that measure the levels of various enzymes and proteins in the blood that are produced by the kidneys. These tests are done to look for kidney damage, which can occur in autoimmune bullous disease.
- C-reactive protein (CRP): C-reactive protein is a blood test that measures the levels of a protein that is produced by the liver in response to inflammation. Elevated levels of CRP may be associated with autoimmune bullous disease.
- Erythrocyte sedimentation rate (ESR): Erythrocyte sedimentation rate is a blood test that measures how quickly red blood cells settle to the bottom of a test tube. Elevated ESR may be associated with autoimmune bullous disease.
- Anti-nuclear antibody (ANA): Anti-nuclear antibody is a blood test that detects antibodies that may be associated with autoimmune diseases.
- Anti-double-stranded DNA antibody (anti-dsDNA): Anti-double-stranded DNA antibody is a blood test that detects antibodies that may be associated with autoimmune diseases.
- Anti-neutrophil cytoplasmic antibody (ANCA): Anti-neutrophil cytoplasmic antibody is a blood test that detects antibodies that may be associated with autoimmune diseases.
- Anti-phospholipid antibody (aPL): Anti-phospholipid antibody is a blood test that detects antibodies that may be associated
Treatment
Pharmacological
The treatment of MABD is challenging as the medications used may have adverse effects on both the mother and the fetus. Here is a list of 20 treatments for MABD, including their details.
- Topical corticosteroids: Topical corticosteroids are the first line of treatment for mild MABD. They can reduce inflammation and blistering. They are applied directly to the skin and have minimal systemic effects.
- Topical calcineurin inhibitors: Topical calcineurin inhibitors like tacrolimus and pimecrolimus are alternative treatments for mild MABD. They are applied directly to the skin and can reduce inflammation and blistering.
- Systemic corticosteroids: Systemic corticosteroids like prednisone are used to treat moderate to severe MABD. They can reduce inflammation and blistering throughout the body. However, they have many side effects and should be used with caution.
- Immunosuppressants: Immunosuppressants like azathioprine, mycophenolate mofetil, and cyclosporine can be used to treat moderate to severe MABD. They can suppress the immune system and reduce inflammation and blistering. However, they have many side effects and should be used with caution.
- Intravenous immunoglobulin: Intravenous immunoglobulin (IVIG) can be used to treat severe MABD. IVIG is a mixture of antibodies that can neutralize the antibodies responsible for MABD. IVIG can be given during pregnancy, but it is expensive and may have side effects.
- Plasmapheresis: Plasmapheresis is a procedure where the plasma is removed from the blood and replaced with a substitute. Plasmapheresis can be used to treat severe MABD by removing the antibodies responsible for MABD. Plasmapheresis is expensive and may have side effects.
- Rituximab: Rituximab is a monoclonal antibody that targets B cells. B cells produce the antibodies responsible for MABD. Rituximab can be used to treat severe MABD, but it is expensive and may have side effects.
- IVIG plus plasmapheresis: IVIG plus plasmapheresis can be used to treat severe MABD. IVIG neutralizes the antibodies responsible for MABD, and plasmapheresis removes the antibodies from the blood. This combination therapy can be effective, but it is expensive and may have side effects.
- Intravenous cyclophosphamide: Intravenous cyclophosphamide is a chemotherapy drug that can suppress the immune system. It can be used to treat severe MABD, but it has many side effects and should be used with caution.
- Tacrolimus ointment: Tacrolimus ointment is a topical calcineurin inhibitor that can be used to treat oral and genital MABD. It can reduce inflammation and blistering in these areas.
- Dapsone: Dapsone is an antibiotic that can also act as an anti-inflammatory agent. It can be used to treat mild to moderate MABD, but it has many side effects and should be used with caution.
- Cyclophosphamide: Cyclophosphamide is an immunosuppressant drug that is used to treat severe and refractory bullous pemphigoid and pemphigoid gestationis. It should be avoided during pregnancy due to the risk of fetal harm.
- Colchicine: Colchicine is an anti-inflammatory drug that is used to treat pemphigoid gestationis. It is generally safe to use during pregnancy.
References
Previous
